eMedicine Specialties > Vascular Surgery > Medical Topics
Peripheral Arterial Occlusive Disease
Updated: Oct 26, 2009
Introduction
Background
Claudication, which is defined as reproducible ischemic muscle pain, is one of the most common manifestations of peripheral vascular disease caused by atherosclerosis. Claudication occurs during physical activity and is relieved after a short rest. Pain develops because of inadequate blood flow.
Pathophysiology
Single or multiple arterial stenoses produce impaired hemodynamics at the tissue level in patients with peripheral arterial occlusive disease (PAOD). Arterial stenoses lead to alterations in the distal pressures available to affected muscle groups and to blood flow.
Peripheral arterial occlusive disease. This angiogram shows a superficial femoral artery occlusion on one side (with reconstitution of the suprageniculate popliteal artery) and superficial femoral artery stenosis on the other side. This is the most common area for peripheral vascular disease.
Under resting conditions, normal blood flow to extremity muscle groups averages 300-400 mm/min. Once exercise begins, blood flow increases up to 10-fold owing to the increase in cardiac output and compensatory vasodilation at the tissue level. When exercise ceases, blood flow returns to normal within minutes.
In patients with PAOD, resting blood flow is similar to that of a healthy person. However, during exercise, blood flow cannot maximally increase in muscle tissue because of proximal arterial stenoses. When the metabolic demands of the muscle exceed blood flow, claudication symptoms ensue. At the same time, a longer recovery period is required for blood flow to return to baseline once exercise is terminated.
Similar abnormal alterations occur in distal perfusion pressure in affected extremities. In normal extremities, the mean blood pressure drop from the heart to the ankles is no more than a few millimeters of mercury. In fact, as pressure travels distally, the measured systolic pressure actually increases because of the higher resistance encountered in smaller-diameter vessels.
At baseline, a healthy person may have a higher measured ankle pressure than arm pressure. When exercise begins, no change in measured blood pressure occurs in the healthy extremity.
In the atherosclerotic limb, each stenotic segment acts to reduce the pressure head experienced by distal muscle groups. Correspondingly, at rest, the measured blood pressure at the ankle is less than that of a healthy person. Once physical activity starts, the reduction in pressure produced by the atherosclerotic lesion becomes more significant and the distal pressure is greatly diminished.
The phenomenon of increased blood flow causing decreased pressure distally to an area of stenosis is a matter of physics. Poiseuille calculated energy losses across areas of resistance with varying flow rates by using the following equation, in which Q is flow, v is viscosity, L is the length of the stenotic area, r is the radius of the open area within the stenosis, and k is constant:
Resistance = pressure = Q8vL/kr4
Applying this equation, the pressure gradient is directly proportional to the flow and length of stenosis and inversely proportional to the fourth power of the radius.
Therefore, while increasing the rate of flow directly increases the pressure gradient at any given radius, these effects are much less marked than those due to changes in the radius of the stenosis.
As the radius is raised to the fourth power, it has the most dramatic impact on a pressure gradient across a lesion. This impact is additive when 2 or more occlusive lesions are located sequentially within the same artery.
Frequency
United States
Atherosclerosis affects up to 10% of the Western population older than 65 years. With the elderly population expected to increase 22% by the year 2040, atherosclerosis is expected to have a huge financial impact on medicine. When claudication is used as an indicator, estimates are that 2% of the population aged 40-60 years and 6% older than 70 years are affected.
Mortality/Morbidity
The most feared consequence is severe limb-threatening ischemia leading to amputation. However, studies of large patient groups with claudication reveal that amputation is uncommon. Boyd prospectively followed 1440 patients with intermittent claudication for as long as 10 years and reported that only 12.2% required amputation.1 In the Framingham study, only 1.6% of patients with claudication reached the amputation stage after 8.3 years of follow-up.
- Limb amputation largely depends on the number and severity of cardiovascular risk factors (ie, smoking, hypertension, diabetes). Continued smoking has been identified as the most consistent adverse risk factor associated with the progression of peripheral arterial occlusive disease (PAOD). Other factors are the severity of disease at the time of the initial patient encounter and, in some studies, the presence of diabetes.
- As with most patients with vascular disease, survival is less than that of age-matched control groups. Coronary artery disease with a subsequent myocardial event is the major contributor to outcome. Predicted mortality rates for patients with claudication at 5, 10, and 15 years of follow-up are approximately 30%, 50%, and 70%, respectively.
Race
- Peripheral arterial occlusive disease (PAOD) has no racial predilection.
Sex
- Intermittent claudication most commonly manifests in men older than 50 years.
- Although younger patients may present with symptoms consistent with intermittent claudication, other etiologies of leg pain and claudication (eg, popliteal entrapment syndrome) must be strongly considered.
Clinical
History
Intermittent claudication typically causes pain that occurs with physical activity. Determining how much physical activity is needed before the onset of pain is crucial.
- Typically, vascular surgeons relate the onset of pain to a particular walking distance in terms of street blocks (eg, 2-block claudication). This helps to quantify patients with some standard measure of walking distance before and after therapy.
- Other important aspects of claudication pain are that the pain is reproducible within the same muscle groups and that it ceases with a resting period of 2-5 minutes.
- Location of the pain is determined by the anatomical location of the arterial lesions. Peripheral arterial occlusive disease (PAOD) is most common with the distal superficial femoral artery (located just above the knee joint), which corresponds to claudication in the calf muscle area (the muscle group just distal to the arterial disease).
- When atherosclerosis is distributed throughout the aortoiliac area, thigh and buttock muscle claudication predominates.
- The perceived significance of claudication is variable. Most patients appear to accept a decrease in walking distance as a normal part of aging. Investigators report that 50-90% of patients with definite intermittent claudication do not report this symptom to their clinician.
- Atherosclerosis is a systemic disease process. Patients who present with claudication due to PAOD can be expected to have atherosclerosis elsewhere. A full assessment of the patient's risk factors for vascular disease should be performed.
- The risk factors for PAOD are the same as those for coronary artery disease or cerebrovascular disease and include diabetes, hypertension, hyperlipidemia, family history, sedentary lifestyle, and tobacco use.
- Smoking is the greatest of all the cardiovascular risk factors. The mechanism by which smoking causes or accentuates atherosclerosis is unknown. What is known is that the degree of damage is directly related to the amount of tobacco used. Counseling patients on the importance of smoking cessation is paramount in PAOD management.
Physical
Essential to the physical examination of a patient with claudication is a complete lower extremity evaluation and pulse examination, including measuring segmental pressures (see Image 1). Atrophy of calf muscles, loss of extremity hair, and thickened toenails are clues to underlying peripheral arterial occlusive disease (PAOD).- Palpation of pulses should be attempted from the abdominal aorta to the foot, with auscultation for bruits in the abdominal and pelvic regions. This can be difficult in a patient who is obese, in whom palpable pulses may be hidden under a deep subcutaneous layer.
- Except in the rare case of a congenital absence of a pulse (eg, persistent sciatic artery), the absence of a pulse signifies arterial obstruction proximal to the area palpated. For example, if no femoral artery pulse is palpated, significant PAOD is present in the aortoiliac distribution. The same can be said if no palpable popliteal artery pulse is present because of existing superficial femoral artery occlusive disease.
- Patients who report intermittent claudication and have palpable pulses can present a clinical dilemma.
- If the history is consistent with typical claudication symptoms, the clinician can have the patient walk around the office (or perform toe raises) until the symptoms are reproduced and then palpate for pulses.
- The exercise should cause the atherosclerotic lesion to become significant and should diminish the strength of the pulses distal to the lesion.
- When palpable pulses are not present, further assessment of the circulation can be made with a handheld Doppler device.
- An audible Doppler signal assures the clinician that some blood flow is perfusing the extremity.
- If no Doppler signals can be heard, a vascular surgeon should be immediately consulted.
- Pressure measurements can be performed to gain objective data on the circulatory status.
- To obtain an accurate pressure reading, (1) place the pneumatic cuff around the ankle, (2) position the Doppler probe over the dorsalis pedis or posterior tibial artery, and (3) inflate the cuff to a reading above the systolic pressure and deflate. The systolic tone at the ankle vessel is the pressure recorded.
- A healthy person has no pressure drop from the heart to the ankle. In fact, the pressure at the ankle may be 10-20 mm Hg higher due to the augmentation of the pressure wave with travel distally.
- In patients with claudication, the measured pressure is diminished to some extent, depending on the severity of PAOD.
- A useful tool in assessing a patient with claudication is the ankle-brachial index (ABI), which is calculated as the ratio of systolic blood pressure at the ankle to the arm.
- Determining the ABI provides an assessment of the impact that the PAOD is having on the patient. A normal ABI is 0.9-1.1. However, any patient with an ABI less than 0.9, by definition, has some degree of PAOD. The ABI decreases with worsening PAOD.
- One area of inaccuracy with the ABI is in patients with diabetes who have PAOD. Peripheral vessels in patients with diabetes may have extensive medial layer calcinosis, rendering the vessel resistant to compression by the pneumatic cuff. These patients should be referred to a vascular laboratory for further evaluation.
More on Peripheral Arterial Occlusive Disease |
Overview: Peripheral Arterial Occlusive Disease |
| Differential Diagnoses & Workup: Peripheral Arterial Occlusive Disease |
| Treatment & Medication: Peripheral Arterial Occlusive Disease |
| Follow-up: Peripheral Arterial Occlusive Disease |
| Multimedia: Peripheral Arterial Occlusive Disease |
| References |
| Next Page » |
References
Boyd AM. The natural course of arteriosclerosis of the lower extremities. Angiology. 1960;11:10.
[Best Evidence] Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol. Sep 8 2009;54(11):989-96. [Medline].
O'Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease. J Vasc Surg. May 2009;49(5):1226-34. [Medline].
Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg. Oct 2009;38(4):463-74. [Medline].
Samson RH. The role of statin drugs in the management of the peripheral vascular patient. Vasc Endovascular Surg. Aug-Sep 2008;42(4):352-66. [Medline].
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. Apr 2007;45(4):645-654; discussion 653-4. [Medline].
Cassar K, Bachoo P, Ford I, et al. Platelet activation is increased in peripheral arterial disease. J Vasc Surg. Jul 2003;38(1):99-103. [Medline].
Clifford PC, Davies PW, Hayne JA, Baird RN. Intermittent claudication: is a supervised exercise class worth while?. Br Med J. Jun 21 1980;280(6230):1503-5. [Medline].
Collins TC, Petersen NJ, Suarez-Almazor M, Ashton CM. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. Jun 23 2003;163(12):1469-74. [Medline].
Couch NP. On the arterial consequences of smoking. J Vasc Surg. May 1986;3(5):807-12. [Medline].
Cronenwett JL, Warner KG, Zelenock GB, et al. Intermittent claudication. Current results of nonoperative management. Arch Surg. Apr 1984;119(4):430-6. [Medline].
Ekroth R, Dahllof AG, Gundevall B, et al. Physical training of patients with intermittent claudication: indications, methods, and results. Surgery. Nov 1978;84(5):640-3. [Medline].
Green RM, McNamara J. The effects of pentoxifylline on patients with intermittent claudication. J Vasc Surg. Feb 1988;7(2):356-62. [Medline].
Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J. May 27 1978;1(6124):1379-81. [Medline].
Jonason T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand. 1985;218(1):27-33. [Medline].
Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. Jan 1985;33(1):13-8. [Medline].
Kannel WB, Skinner JJ, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation. May 1970;41(5):875-83. [Medline].
Porter JM, Cutler BS, Lee BY, et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J. Jul 1982;104(1):66-72. [Medline].
Reid DD, Brett GZ, Hamilton PJ, et al. Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet. Mar 23 1974;1(7856):469-73. [Medline].
Rosenbloom MS, Flanigan DP, Schuler JJ, et al. Risk factors affecting the natural history of intermittent claudication. Arch Surg. Jul 1988;123(7):867-70. [Medline].
Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol. May 1992;45(5):529-42. [Medline].
Walsh DB, Gilbertson JJ, Zwolak RM, et al. The natural history of superficial femoral artery stenoses. J Vasc Surg. Sep 1991;14(3):299-304. [Medline].
Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg. Apr 2009;49(4):910-7. [Medline].
Further Reading
Keywords
peripheral arterial occlusive disease, PAOD, chronic arterial insufficiency, lower extremity claudication, lower extremity ischemia, lower-extremity claudication, lower-extremity ischemia, peripheral vascular disease, cholesterol, smoking, hypertension




Overview: Peripheral Arterial Occlusive Disease